When was SquareMind founded?

SquareMind was founded in 2019 and raised its 1st funding round 3 years after it was founded.

Where is SquareMind located?

SquareMind is headquartered in Paris, France.

Who is the current CEO of SquareMind?

Ali Khachlouf of SquareMind. They have also founded 1 company.

Is SquareMind a funded company?

SquareMind is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2022.

When was the latest funding round of SquareMind?

SquareMind's latest funding was a $***** Grant (prize money) round on Jul 01, 2022, with participation from 1 investor.

Where does SquareMind rank among its competitors?

SquareMind ranks 14th amongst 70 active competitors, of which 17 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was DermaSensor, which secured $16M in Oct, 2025.

Who are the top competitors of SquareMind?

SquareMind's top competitors include DermaSensor, SciBase and Spotitearly. Among them, DermaSensor secured the most recent funding round in October, 2025.

SquareMind - 2026 Company Profile, Team, Funding & Competitors

SquareMind is a funded company based in Paris (France), founded in 2019 by Ali Khachlouf. It operates as a Developer of robotic medical equipment for skin cancer detection. SquareMind has raised an undisclosed amount in funding. The company has 70 active competitors, including 17 funded and 3 that have exited. Its top competitors include companies like DermaSensor, SciBase and Spotitearly.

Company Details

Developer of robotic medical equipment for skin cancer detection. It offers autonomous robots equipped with third-dimension construction software that capture data by full-body mapping to detect skin cancer. It allow physicians to track the growth of moles on the body using off-the-shelf robots.

Website: squaremind.com/en/
Email ID: *****@squaremind.io

Key Metrics

Founded Year

2019

Location

Paris, France

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Jul 01, 2022, $*****

Investors

Entrepreneur First & 4 more

Ranked

14^th among 70 active competitors

Similar Companies

DermaSensor & 81 more

View SquareMind's full profile

SquareMind has raised funding over 2 rounds. Its first funding round was on 2022. Its latest funding round was a Grant (prize money) round on Jul 01, 2022 for $*****. 1 investor participated in its latest round. SquareMind has 5 institutional investors.

Here is the list of recent funding rounds of SquareMind:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 01, 2022	6165991	Grant (prize money)	8350608	9354534	3642425	3915720
2022	7351	Grant (prize money)	5665	5822	3567	EIC Fund

Access funding benchmarks and valuations. Sign up today!

View details of SquareMind's funding rounds and investors

The founders of SquareMind is Ali Khachlouf. Ali Khachlouf is the CEO of SquareMind.

Here are the details of SquareMind's key team members:

Ali Khachlouf: Co-Founder & CEO of SquareMind and founder of 1 other company.

View details of SquareMind's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SquareMind include DermaSensor, SciBase and Spotitearly. Here is the list of Top 10 competitors of SquareMind, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	DermaSensor 2009, Miami (United States), Series B	Developer of an AI-powered skin cancer detection device	$60.7M	Ceros Capital Markets, SternAegis Ventures ... & 11 others	60/100
2nd	SciBase 1998, Stockholm (Sweden), Public	Provider of POC device for the detection of malignant melanoma	$22.3M	ÖstVäst Advisory AB, Omega Funds & 5 others	58/100
3rd	Spotitearly 2020, Tel Aviv (Israel), Seed	AI-based cancer detection device for providers	$26.5M	Hanaco Ventures & 5 others	50/100
4th	Panakeia 2018, London (United Kingdom), Seed	Provider of AI-based software for diagnosis and precision treatment	$3.79M	LocalGlobe, Entrepreneur First & 4 others	50/100
5th	Astrin 2021, Saint Paul (United States), Series B	AI-empowered 3D holographic imaging platform for early cancer detection	$22.9M	HHS	47/100
6th	DAMAE Medical 2014, Paris (France), Series A	Developer of imaging diagnostic device for skin cancer	$10M	Paris Saclay Seed Fund, Kurma Partners & 5 others	45/100
7th	Vivosight 2006, Maidstone (United Kingdom), Series B	Provider of optical coherence tomography diagnostic device for dermatology	$8.9M	Smith & Nephew, The Secretary Of State For Energy and Industrial Strategy ... & 122 others	45/100
8th	MedLumics 2009, Madrid (Spain), Series E	Developer of biological tissue imaging by using optical coherence tomography	$62.8M	Edmond de Rothschild, VI Partners & 11 others	45/100
9th	GynEye 2013, Hyderabad (India), Unfunded	Provider of a smart colposcope for cervical and vulvar screening	-	-	44/100
10th	Michelson Diagnostics 2006, Maidstone (United Kingdom), Deadpooled	Point-of-care Optical Coherence Tomography(OCT) device for dermatology	$14.9M	Octopus Ventures, Catapult Ventures & 79 others	41/100
14th	SquareMind 2019, Paris (France), Funding Raised	Developer of robotic medical equipment for skin cancer detection	-	Entrepreneur First, Id4 ventures & 3 others	36/100